Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China
· Delayed Price · Currency is CNY 50.90
+0.01 (0.02%)
Apr 29, 2026, 3:00 PM CST
SHA:688050 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 9,844 | 11,732 | 17,254 | 18,107 | 24,264 | 22,103 | Upgrade
|
| Market Cap Growth | -46.99% | -32.01% | -4.71% | -25.37% | 9.78% | 21.53% | Upgrade
|
| Enterprise Value | 10,611 | 11,882 | 17,625 | 17,747 | 24,232 | 21,769 | Upgrade
|
| Last Close Price | 50.90 | 60.66 | 90.57 | 94.78 | 126.81 | 115.35 | Upgrade
|
| PE Ratio | 37.06 | 43.75 | 44.42 | 59.57 | 104.27 | 129.00 | Upgrade
|
| Forward PE | 22.64 | 26.56 | 29.85 | 46.16 | 81.03 | 105.28 | Upgrade
|
| PS Ratio | 6.46 | 7.91 | 12.24 | 19.04 | 41.87 | 51.04 | Upgrade
|
| PB Ratio | 3.15 | 3.95 | 6.55 | 7.69 | 12.64 | 12.70 | Upgrade
|
| P/TBV Ratio | 4.99 | 4.88 | 8.30 | 9.93 | 14.01 | 14.16 | Upgrade
|
| P/FCF Ratio | 45.92 | 47.69 | 944.35 | - | - | - | Upgrade
|
| P/OCF Ratio | 31.52 | 31.78 | 49.62 | 85.16 | 97.01 | 100.79 | Upgrade
|
| PEG Ratio | - | 1.31 | 1.31 | 1.31 | 1.94 | 2.52 | Upgrade
|
| EV/Sales Ratio | 6.96 | 8.01 | 12.50 | 18.66 | 41.82 | 50.27 | Upgrade
|
| EV/EBITDA Ratio | 18.11 | 21.07 | 31.16 | 46.64 | 89.28 | 115.75 | Upgrade
|
| EV/EBIT Ratio | 26.09 | 29.49 | 40.29 | 57.59 | 104.62 | 137.88 | Upgrade
|
| EV/FCF Ratio | 49.50 | 48.30 | 964.66 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.20 | 0.23 | 0.18 | 0.09 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 2.10 | 1.01 | 1.07 | 1.09 | 0.59 | 0.82 | Upgrade
|
| Debt / FCF Ratio | 5.75 | 2.36 | 33.33 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | -0.07 | 0.04 | -0.06 | -0.35 | -0.46 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.88 | -0.38 | 0.20 | -0.36 | -2.48 | -4.25 | Upgrade
|
| Net Debt / FCF Ratio | 2.35 | -0.88 | 6.17 | 0.87 | 32.25 | 8.69 | Upgrade
|
| Asset Turnover | 0.37 | 0.40 | 0.43 | 0.36 | 0.27 | 0.24 | Upgrade
|
| Inventory Turnover | 1.65 | 1.85 | 2.11 | 1.77 | 1.31 | 1.18 | Upgrade
|
| Quick Ratio | 2.29 | 3.01 | 2.86 | 2.05 | 6.39 | 7.37 | Upgrade
|
| Current Ratio | 3.11 | 3.94 | 3.95 | 2.71 | 7.19 | 8.02 | Upgrade
|
| Return on Equity (ROE) | 8.17% | 8.59% | 15.51% | 13.38% | 12.42% | 10.21% | Upgrade
|
| Return on Assets (ROA) | 6.13% | 6.82% | 8.34% | 7.26% | 6.75% | 5.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.51% | 12.19% | 15.82% | 15.53% | 18.22% | 17.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.80% | 11.60% | 13.70% | 11.50% | 11.00% | 8.30% | Upgrade
|
| Earnings Yield | 2.69% | 2.29% | 2.25% | 1.68% | 0.96% | 0.78% | Upgrade
|
| FCF Yield | 2.18% | 2.10% | 0.11% | -0.87% | -0.09% | -0.42% | Upgrade
|
| Dividend Yield | 0.69% | - | 0.39% | 0.29% | 0.22% | 0.18% | Upgrade
|
| Payout Ratio | 33.50% | 33.36% | 18.17% | 20.19% | 19.10% | 17.81% | Upgrade
|
| Buyback Yield / Dilution | -2.01% | -1.10% | 0.27% | -0.25% | -0.17% | -17.57% | Upgrade
|
| Total Shareholder Return | -1.34% | -1.10% | 0.66% | 0.04% | 0.06% | -17.39% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.